Skip to content

Clinical trials

Withdrawn Phase 3 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Status: Withdrawn Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20121
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merz North America, Inc.2
Allerderm1
Brigham and Women's Hospital1
Connect Biopharm LLC1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity6
Dermatitis, Atopic3
Eczema3
Pruritus3
Dermatitis2
Exanthema2
Genetic Diseases, Inborn2
Hypersensitivity, Immediate2
Immune System Diseases2
Skin Diseases2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.